Study of MEK162 for Children With Low-Grade Gliomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nathan Robison, MD
CHLA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital of Colorado
Aurora, Colorado, United States
- Children'S National Heath Systems
Washington D.C., District of Columbia, United States
- Nicklaus Children'S Hospital
Miami, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Children'S Hospitals and Clinics of Minnesota-Minneapolis
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- New York University
New York, New York, United States
- Oregon Health and Science University
Portland, Oregon, United States
- University of Texas Southwestern Medical
Dallas, Texas, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 May 2016
- Primary completion
- 2 Nov 2022
- Completion
- 1 Aug 2025
- Last update posted
- 7 Oct 2025
- Registered enrollment
- 105
- Registry id
- NCT02285439
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.